Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookDrugs Formulary for Health Center - Ethiopia (DACA; 2004; 222 pages)
View the documentACKNOWLEDGEMENTS
View the documentINTRODUCTION
Open this folder and view contentsGENERAL ADVICE TO PRESCRIBERS
Open this folder and view contents2. CARDIOVASCULAR DRUGS
Open this folder and view contents3. RESPIRATORY DRUGS
Open this folder and view contents4. CENTRAL NERVOUS SYSTEM DRUGS
Open this folder and view contents5. DRUGS USED IN ANESTHESIA
Open this folder and view contents6. DRUGS USED IN MUSCULOSKELETAL AND JOINT DISEASE
close this folder7. ANTI-INFECTIVE
Open this folder and view contents7.1. Antibacterials
View the document7.2. Antifungals
View the document7.3. Antiviral
Open this folder and view contents7.4. Antiprotozoals
Open this folder and view contents7.5. Anthelmintics
Open this folder and view contents8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
View the document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
Open this folder and view contents10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
Open this folder and view contents11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
Open this folder and view contents12. VITAMINS
Open this folder and view contents13. ANTIHISTAMINES AND ANTIALLERGICS
Open this folder and view contents14. OPHTHALMIC AGENTS
Open this folder and view contents15. EAR, NOSE, AND THROAT PREPARATIONS
Open this folder and view contents16. DERMATOLOGIC AGENTS
View the document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
View the document18. IMMUNOLOGICAL PREPARATIONS
View the document19. MISCELLANEOUS
View the documentAPPENDIXES
View the documentGLOSSARY
View the documentADVERSE DRUG REACTION REPORTING FORM
View the documentBACK COVER
 

7.3. Antiviral

Acyclovir

Tablet, 200mg, 400mg
Powder for injection, 250mg, 500mg in vial

Indications: - viral infections due to herpes simplex virus (types 1 and 2) and varicella-zoster virus (herpes zoster and chickenpox); see also under dose.

Cautions: - renal impairment (dose should be adjusted), rapid or bolus injection should be avoided and adequate hydration maintained; pregnancy and breast-feeding; see also interaction.

Drug interactions: - probenecid, any nephrotoxic drugs.

Side effects: - nausea, vomiting abdominal pain, diarrhea, headache, fatigue, rash urticaria, pruritus, photosensitivity; rarely hepatitis, jaundice, dyspnoea, angioedema, anaphylaxis, neurological reactions (including dizziness, confusion, hallucinations and drowsiness), acute renal failure, decreases in hematological indices; on intravenous infusion, severe local inflammation (sometimes leading to ulceration), fever, and rarely agitation, tremors, psychosis and convulsions.

Dose and Administration:

By mouth,

Herpes simplex, treatment, 200mg (400mg in the immunocompromised or if absorption impaired) 5 times daily, usually for 5 days; CHILD under 2 years, half adult dose, over 2 years, adult dose.

Herpes simplex, prevention of recurrence, 200mg 4 times daily or 400mg twice daily possibly reduced to 200mg 2 or 3 times daily and interrupted every 6-12 months.

Herpes simplex, prophylaxis in the immunocompromised, 200-400mg 4 times daily; CHILD under 2 years, half adult dose; over 2 years, adult dose

Varicella and herpes zoster, treatment, 800mg 5 times daily for 7 days; CHILD, varicella, 20mg/kg (max. 800mg) 4 times daily for 5 days or under 2 years 200mg 4 times daily, 2-5 years 400mg 4 times daily, over 6 years 800mg 4 times daily.

Intravenous infusion, treatment of herpes simplex in the immunocompromised, severe initial genital herpes, and varicella-zoster, 5mg/kg every 8 hours usually for 5 days, doubled to 10mg/kg every 8 hours usually in varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis); prophylaxis of herpes simplex in the immunocopromised, 5mg/kg every 8 hours. NEONATE up to 3 months, herpes simplex, 10mg/kg every 8 hours usually for 10 days; CHILD 3 months-12 years, herpes simplex or varicella-zoster in immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis)

to previous sectionto next section

Please provide your feedback English  |  French